Apoptosis signal-regulating kinase-1 inhibitor as a potent therapeutic drug for the treatment of gastric cancer

Cancer Science

Volumn 103, Issue 12, 2012, Pages 2181-2185

  Hayakawa, Yoku ^a   Hirata, Yoshihiro ^a   Sakitani, Kosuke ^a   Nakagawa, Hayato ^a   Nakata, Wachiko ^a   Kinoshita, Hiroto ^a   Takahashi, Ryota ^a   Takeda, Kohsuke ^b,d   Ichijo, Hidenori ^b   Maeda, Shin ^a,c   Koike, Kazuhiko ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c YOKOHAMA CITY UNIVERSITY   (Japan)

^d NAGASAKI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APOPTOSIS SIGNAL REGULATING KINASE 1 INHIBITOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; K 811; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; TUMOR MARKER; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME INHIBITION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; HELA CELLS; HUMANS; MAP KINASE KINASE KINASE 5; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; RECEPTOR, ERBB-2; STOMACH NEOPLASMS; TRANSPLANTATION, HETEROLOGOUS; UP-REGULATION;

EID: 84870675515     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12024     Document Type: Article

References (23)

1. Sugimoto T, Okamoto M, Mitsuno Y et al. Endoscopic submucosal dissection is an effective and safe therapy for early gastric neoplasms: a multicenter feasible study. J Clin Gastroenterol 2012; 46: 124-9.
2. Sano T, Sasako M, Yamamoto S et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy-Japan Clinical Oncology Group study 9501. J Clin Oncol 2004; 22: 2767-73.
3. Wagner AD, Grothe W, Haerting J, Kleber G, Grothey A, Fleig WE. Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data. J Clin Oncol 2006; 24: 2903-9.
4. Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 2001; 345: 784-9.
5. Sakitani K, Hirata Y, Watabe H et al. Gastric cancer risk according to the distribution of intestinal metaplasia and neutrophil infiltration. J Gastroenterol Hepatol 2011; 26: 1570-5.
6. Hirata Y, Maeda S, Mitsuno Y et al. Helicobacter pylori activates the cyclin D1 gene through mitogen-activated protein kinase pathway in gastric cancer cells. Infect Immun 2001; 69: 3965-71.
7. Hirata Y, Ohmae T, Shibata W et al. MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J Immunol 2006; 176: 3796-803.
8. Maeda S, Yoshida H, Ogura K et al. H. pylori activates NF-kappaB through a signaling pathway involving IkappaB kinases, NF-kappaB-inducing kinase, TRAF2, and TRAF6 in gastric cancer cells. Gastroenterology 2000; 119: 97-108.
9. Mitsuno Y, Yoshida H, Maeda S et al. Helicobacter pylori induced transactivation of SRE and AP-1 through the ERK signalling pathway in gastric cancer cells. Gut 2001; 49: 18-22.
10. Sakamoto K, Hikiba Y, Nakagawa H et al. Inhibitor of kappaB kinase beta regulates gastric carcinogenesis via interleukin-1alpha expression. Gastroenterology 2010; 139: 226-38.e6.
11. Arsene D, Galais MP, Bouhier-Leporrier K, Reimund JM. Recent developments in colorectal cancer treatment by monoclonal antibodies. Expert Opin Biol Ther 2006; 6: 1175-92.
12. Ohtsu A, Shah MA, Van Cutsem E et al. Bevacizumab in combination with chemotherapy as first-line therapy in advanced gastric cancer: a randomized, double-blind, placebo-controlled phase III study. J Clin Oncol 2011; 29: 3968-76.
13. Lordick F, Luber B, Lorenzen S et al. Cetuximab plus oxaliplatin/leucovorin/5-fluorouracil in first-line metastatic gastric cancer: a phase II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO). Br J Cancer 2010; 102: 500-5.
14. Bang YJ, Van Cutsem E, Feyereislova A et al. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial. Lancet 2010; 376: 687-97.
15. Hayakawa Y, Hirata Y, Nakagawa H et al. Apoptosis signal-regulating kinase 1 and cyclin D1 compose a positive feedback loop contributing to tumor growth in gastric cancer. Proc Natl Acad Sci USA 2011; 108: 780-5.
16. Nakata W, Hayakawa Y, Nakagawa H et al. Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer. Int J Oncol 2011; 39: 1529-36.
17. Sakamoto K, Maeda S, Hikiba Y et al. Constitutive NF-kappaB activation in colorectal carcinoma plays a key role in angiogenesis, promoting tumor growth. Clin Cancer Res 2009; 15: 2248-58.
18. Takeda K, Shimozono R, Noguchi T et al. Apoptosis signal-regulating kinase (ASK) 2 functions as a mitogen-activated protein kinase kinase kinase in a heteromeric complex with ASK1. J Biol Chem 2007; 282: 7522-31.
19. Saitoh M, Nishitoh H, Fujii M et al. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J 1998; 17: 2596-606.
20. Hayakawa Y, Maeda S, Nakagawa H et al. Effectiveness of IkappaB kinase inhibitors in murine colitis-associated tumorigenesis. J Gastroenterol 2009; 44: 935-43.
21. Ichijo H, Nishida E, Irie K et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 1997; 275: 90-4.
22. Hayakawa Y, Hirata Y, Nakagawa H et al. Apoptosis signal-regulating kinase 1 regulates colitis and colitis-associated tumorigenesis by the innate immune responses. Gastroenterology 2010; 138: 1055-67.e1-4.
23. Nakagawa H, Hirata Y, Takeda K et al. Apoptosis signal-regulating kinase 1 inhibits hepatocarcinogenesis by controlling the tumor-suppressing function of stress-activated mitogen-activated protein kinase. Hepatology 2011; 54: 185-95.